Advertisers have just discovered that Indian gamers are more valuable than television viewers, social media scrollers, and newspaper readers combined—and the numbers prove it. India’s gaming industry reached ₹33,243 crore (approximately $4.4 billion) in 2024, growing at a 15% compound annual growth rate through the next decade. Over 680 million smartphone users now game regularly, […]
India’s healthcare system has just bypassed hospitals entirely, moving care directly into homes, workplaces, and neighborhood clinics through digital infrastructure most patients didn’t know existed. Healthtech startups raised ₹68,724 crore in the first half of 2025 alone, representing a 462% rise in monthly funding since April. This capital surge isn’t funding more hospital beds—it’s building
Fashion and beauty brands have just discovered that their customers have zero patience for generic experiences—and the numbers prove it’s existential. McKinsey’s State of Beauty 2025 report reveals that 71% of consumers now expect brands to deliver customized interactions, whilst 76% will switch brands if those expectations aren’t met immediately. This isn’t a gradual preference
The 2025 ban on real-money gaming looked like an extinction event for India’s gaming industry—until companies discovered they had been building on unstable foundations anyway. The Promotion and Regulation of Online Gaming Bill eliminated cash-stake games overnight, forcing developers and publishers into complete business model transformations within months. What appeared catastrophic actually accelerated evolution toward
The country’s gaming industry has exploded into a ₹33,243 crore (approximately $4.5 billion) phenomenon that fundamentally reshapes how advertisers reach consumers. This isn’t merely an entertainment evolution—it represents a seismic shift in marketing strategy, where immersive experiences replace passive viewing. Digital penetration, smartphone ubiquity, affordable internet, and gaming’s social acceptance have converged to create India’s
India’s Gaming Boom: How ₹33,243 Crore Creates Advertiser Paradise Read More »
India’s infrastructure giant PNC Infratech has made a calculated bet on the country’s renewable energy future. The company launched PNC Renewable Energy Private Limited, signalling strategic diversification beyond highways and bridges into solar and wind power development. This isn’t a tentative toe-dip into clean energy; it represents a deliberate portfolio expansion by an established infrastructure
PNC Infratech Pivots to Green Energy With New Subsidiary Launch Read More »
India’s renewable energy sector just witnessed another blockbuster transaction. KPI Green Energy has clinched a ₹696.50 crore contract from SJVN Limited, cementing its position among India’s solar development heavyweights. This isn’t merely another corporate announcement buried in financial pages. The 200 MW solar project represents tangible progress towards India’s audacious 500 GW non-fossil fuel capacity
KPI Green Energy Lands ₹696.50 Crore SJVN Solar Deal Read More »
India’s healthcare boom has triggered an environmental emergency that most citizens never see. Every day, over 700 tonnes of potentially lethal waste emerge from hospitals nationwide. Syringes, blood-soaked dressings, pharmaceutical residues, and pathological materials pile up relentlessly. Mishandled, they become biological time bombs threatening communities and ecosystems alike. Yet within this crisis lies a burgeoning
India’s Biomedical Waste Crisis: A Growing Market Amid Healthcare Expansion Read More »
Americans with diabetes face a brutal choice: pay exorbitant insulin prices or ration life-saving medication and risk severe health complications. This isn’t hyperbole—patients regularly skip doses, stretch supplies dangerously thin, or simply go without because insulin costs have spiraled beyond affordability for millions. Biocon Biologics, a global biosimilars leader, has extended its partnership with US-based
Most cancer treatments attack tumours directly with chemicals or radiation—blunt instruments causing collateral damage throughout the body. Theriva Biologics takes a fundamentally different approach: engineering viruses that selectively invade cancer cells, replicate inside them, and trigger immune responses while breaking down the protective barriers tumours build around themselves. This innovative strategy targets some of medicine’s
Theriva Biologics Raises $4 Million: Warrant Deal Fuels Cancer-Fighting Virus Research Read More »
